Boundless Bio Stock Forward View - Day Typical Price
| BOLD Stock | USD 1.14 -0.01 -0.87% |
Predicting where Boundless Bio's stock will trade is more achievable when sentiment data complements traditional analysis. This module isolates the sentiment-driven component of price to highlight potential mispricings.
At this point in time, the 14-period RSI for Boundless Bio stands at 48, indicating moderately negative momentum. This range suggests moderated price movement without extreme directional pressure.Momentum
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter -0.51 | EPS Estimate Current Year -2.38 | EPS Estimate Next Year -1.28 | Wall Street Target Price 4 | EPS Estimate Current Quarter -0.52 |
This section provides headline-driven context for Boundless Bio Common alongside peer activity.
Boundless Bio after-hype prediction price | $ 1.15 |
The sentiment panel provides context that can be compared with forecasting models and technical indicators.
Boundless | Build AI portfolio with Boundless Stock |
Boundless Bio Additional Predictive Modules
Most predictive techniques to examine Boundless price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Boundless using various technical indicators. When you analyze Boundless charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Day Typical Price | Day Typical Price | Trend |
| 1.14 | 1.14 |
| Check Boundless Bio Volatility | Backtest Boundless Bio | Information Ratio |
Boundless Bio Trading Date Momentum
| On March 11 2026 Boundless Bio Common was traded for 1.14 at the closing time. The top price for the day was 1.14 and the lowest listed price was 1.14 . There was no trading activity during the period 0.0. Lack of trading volume on March 11, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.70% . |
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Boundless Bio to competition |
Other Forecasting Options for Boundless Bio
For both new and experienced investors in Boundless, the ability to analyze Boundless Bio's price movement is a fundamental investment skill. Price chart noise in Boundless Stock can create false signals and mislead investment decisions.Boundless Bio Related Equities
The following equities are related to Boundless Bio within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Boundless Bio against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Boundless Bio Market Strength Events
Tracking market strength indicators for Boundless Bio helps investors understand the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Boundless Bio Common for maximum return potential.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.14 | |||
| Day Typical Price | 1.14 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.01 | |||
| Relative Strength Index | 48.78 |
Boundless Bio Risk Indicators
Properly assessing Boundless Bio's risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Boundless Bio's allows investors to make better-informed decisions about accepting or hedging their exposure.
| Mean Deviation | 1.78 | |||
| Semi Deviation | 1.83 | |||
| Standard Deviation | 2.56 | |||
| Variance | 6.58 | |||
| Downside Variance | 5.26 | |||
| Semi Variance | 3.33 | |||
| Expected Short fall | -2.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Boundless Bio
Coverage intensity for Boundless Bio Common matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Boundless Bio Short Properties
Short sentiment tied to Boundless Bio Common matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 22.4 M | |
| Cash And Short Term Investments | 107.6 M |
More Resources for Boundless Stock Analysis
A comprehensive view of Boundless Bio Common starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Boundless Bio Common Stock. Key reports that frame Boundless Bio Common Stock are listed below:Historical Fundamental Analysis of Boundless Bio can be used to cross-verify projections for Boundless Bio. The historical series provides projection context. Analysis related to Boundless Bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Boundless Bio Common market price can diverge from book value, the accounting figure shown on Boundless balance sheet. Boundless Bio's market capitalization is 25.74 M. A P/B ratio of 0.23 suggests Boundless Bio trades near or below book value. Intrinsic value is an analytical estimate of Boundless Bio's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
It is useful to distinguish Boundless Bio's value from its trading price, which are computed with different methods. For Boundless Bio, key inputs include a P/B ratio of 0.23, and ROE of -44.88%. By contrast, market price reflects the level where buyers and sellers transact.